Back to top
more

Teleflex (TFX)

(Delayed Data from NYSE)

$116.06 USD

116.06
513,023

+0.17 (0.15%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $116.03 -0.03 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Hold on to Teleflex (TFX) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Teleflex (TFX) on robust segmental and geographical growth.

Zacks Equity Research

Why Is Teleflex (TFX) Up 8.2% Since Last Earnings Report?

by Zacks Equity Research

Teleflex (TFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Teleflex (TFX) Rides on UroLift Sales Amid Coronavirus Mayhem

by Zacks Equity Research

NeoTract, the acquired business of Teleflex (TFX), continues to perform impressively.

Zacks Equity Research

Teleflex (TFX) Earnings and Revenues Beat Estimates in Q1

by Zacks Equity Research

Teleflex's (TFX) first-quarter 2020 results reflect sales growth across few major segments despite the coronavirus pandemic.

Zacks Equity Research

Teleflex (TFX) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 18.26% and 1.98%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Medical Products Stock Earnings on Apr 30: BAX, IDXX & More

by Zacks Equity Research

The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.

Zacks Equity Research

Teleflex (TFX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Hold on to Teleflex (TFX) Stock Now

by Zacks Equity Research

Investors continue to be optimistic about Teleflex (TFX) on its strong segmental and international growth in the fourth quarter of 2019.

Zacks Equity Research

4 MedTech Stocks Set to Rebound Post Coronavirus-Led Crisis

by Zacks Equity Research

Here are some MedTech stocks which are steadily inching toward a trend reversal after registering record declines over the past few weeks.

Zacks Equity Research

Teleflex (TFX) Down 36.6% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Teleflex (TFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Here's Why You Should Hold on to Teleflex (TFX) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Teleflex (TFX) on its strong segmental and international performance in Q4.

Zacks Equity Research

Teleflex (TFX) Earnings and Revenues Beat Estimates in Q4

by Zacks Equity Research

Teleflex's (TFX) fourth-quarter 2019 results reflect strong segmental performances.

Zacks Equity Research

Teleflex COMFORT FLO System's Voluntary Recall Ranked Class I

by Zacks Equity Research

Teleflex's (TFX) COMFORT FLO Humidification System up for worldwide voluntary recall after the receipt of complaints of device malfunction.

Zacks Equity Research

Teleflex's Bipolar Temporary Pacing Guidewire Gets FDA Nod

by Zacks Equity Research

Teleflex (TFX) receives the FDA clearance for its bipolar temporary pacing guidewire, thus paving the way for improvements in TAVR and BAV procedures.

Zacks Equity Research

Teleflex (TFX) Receives FDA Nod for Expanded Use of UroLift

by Zacks Equity Research

Teleflex (TFX) receives FDA clearance for expanded indication for the utilization of the UroLift System for treating larger prostrates in men.

Zacks Equity Research

Here's Why You Should Hold on to Teleflex (TFX) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Teleflex (TFX) on its strong segmental and international performance in Q3.

Zacks Equity Research

Teleflex Hits New 52-Week High: What's Driving the Rally?

by Zacks Equity Research

Teleflex (TFX) is optimistic about maintaining growth momentum on several recent developments.

Zacks Equity Research

Teleflex (TFX) Earnings and Revenues Beat Estimates in Q3

by Zacks Equity Research

We are encouraged by Teleflex's (TFX) robust improvement in Q3 revenues on balanced growth across majority of segments and all geographies.

Zacks Equity Research

Teleflex (TFX) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 8.00% and 0.78%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More

by Urmimala Biswas

Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.

Zacks Equity Research

Teleflex (TFX) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Hold on to Teleflex (TFX) Stock Now

by Zacks Equity Research

Investor confidence is still high on Teleflex (TFX), thanks to solid prospects.

Zacks Equity Research

Teleflex (TFX) Up 0.7% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Teleflex (TFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Teleflex (TFX) Q2 Earnings Top Estimates, Margins Improve

by Zacks Equity Research

Teleflex (TFX) sees robust revenue improvement across majority of segments and all geographies.

Zacks Equity Research

Teleflex (TFX) Q2 Earnings Top Estimates, Margins Improve

by Zacks Equity Research

Teleflex (TFX) sees robust revenue improvement across majority of segments and all geographies.